| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000014955 |
| Receipt No. | R000017398 |
| Official scientific title of the study | A prospective study for laparoscopic low anterior resection of rectum with lateral pelvic lymph node dissection in patients with advanced lower rectal cancer |
| Date of disclosure of the study information | 2014/09/01 |
| Last modified on | 2016/11/16 (Ver. 8) |
| Basic information | ||
| Official scientific title of the study | A prospective study for laparoscopic low anterior resection of rectum with lateral pelvic lymph node dissection in patients with advanced lower rectal cancer | |
| Title of the study (Brief title) | laparoscopic lateral pelvic lymph node dissection in patients with advanced lower rectal cancer | |
| Region |
|
|
| Condition | ||
| Condition | advanced lower rectal cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the safety and efficacy of laparoscopic lateral lymph node dissection in patients with advanced lower rectal cancer |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | incidence of complication |
| Key secondary outcomes | 3-year local recurrence-free survival,3-year recurrece-free survival,recurrence-free survival,overall survival,operative time,intraoperative bleeding,transition to open surgery,completion of surgery, number of dissected lateral lymph node, voiding dysfunction, hospital days after surgery |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Educational,Counseling,Training | |
| Type of intervention |
|
|
| Interventions/Control_1 | laparoscopic lateral pelvic lymph node dissection | |
| Interventions/Control_2 | lateral lymph node dissection by open surgery | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | (1) Histologically confirmed adenocarcinoma
(2)recquirement to all of follows by preoperative diagnostic imaging 1.invasion depth is more than T3, or metastasis in N1, N2 lymph node 2.Main lesion of the tumor is located at the rectum 3.Lower tumor margin is below the peritoneal reflection 4.No extramesorectal lymph node swelling (Shorter diameter is less than 10 mm) 5.No invasion to other organ (s) (3) no past history of pelvic radiation (4)without multiple malignancies (5)Patient age is more than 20 and less than 75 (6)PS: 0, 1 (7)adequate organ function (8) Written informed consent |
|||
| Key exclusion criteria | 1.Multiple malignancies to be treated
2.Pregnant women, possibly pregnant women, wishing to become pregnant, and nursing mothers. 3.Intestinal bleeding, ileus, bowel obstruction or uncontrolled peptic ulcer 4.Uncontrolled severe complications(DM, hypertension, diarrhea, et al.) 5.Massive pleural effusion or ascites that required drainage. 6.Patient with symptomatic cardiovascular disease or asymptomatic disease but has been treated (>=Grade 2 according to NCI-CTCAE ver.4). History of myocardial infarction within a year. 7.With interstitial lung disease or pulmonary fibrosis 8.Continuous systemic steroid therapy (oral or intravenous administration) 9.A history and/or current evidence of significant neurological and/or mental illness 10.Not appropriate for the study at the physician's assessment |
|||
| Target sample size | 22 | |||
| Research contact person | |
| Name of lead principal investigator | Takashi Kinoshita |
| Organization | Aichi Prefectural cancer center |
| Division name | Colorectal Surgery Division |
| Address | 1-1 Kanokoden Chikusa-ku, Nagoya, Aichi |
| TEL | 052-762-6111 |
| t-kinoshita@h2.dion.ne.jp | |
| Public contact | |
| Name of contact person | Tetsuya Wada |
| Organization | M's system |
| Division name | data center |
| Address | 4902-1-5-D Hirokute Asahimae-cho Owariasahi Aichi |
| TEL | 0561-51-5590 |
| Homepage URL | |
| marobon@dream.com | |
| Sponsor | |
| Institute | Chubu Clinical Oncology Group |
| Institute | |
| Department | |
| Funding Source | |
| Organization | none |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000017398 |